共被期刊论文引用了4次
您的检索式：您选中1篇文献正在查看引证文献汇总
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 糖尿病性白内障与视网膜病变联合治疗的时机和策略显示文摘白内障和视网膜病变常并发于糖尿病患者,临床上常面临白内障和视网膜病变联合治疗的决策问题,包括糖尿病性白内障的手术时机,糖尿病视网膜病变的治疗时机及策略,尤其微切口白内障超声乳化手术联合23G/25G玻璃体切割术以及玻璃体内注射抗血管内皮生长因子和激素等药物为近年的热点问题。随着手术技术、设备、材料和药物的不断进步,使得联合治疗有更多的选择和良好的效果。本文综述了糖尿病性白内障与糖尿病视网膜病变的联合治疗时机及治疗策略的研究进展。 | 沈盛县 严宏 | 2015 | 眼科新进展2015，35，8： | 16 |
| 2 | Diabetic macular edema:Current management 2013显示文摘Diabetic retinopathy(DR)is the leading cause of vision loss of working-age adults,and diabetic macular edema(DME)is the most frequent cause of vision loss related to diabetes.The Wisconsin Epidemiologic Study of Diabetic Retinopathy found the 14-year incidence of DME in type 1 diabetics to be 26%.Similarly the Diabetes Control and Complications Trial reported that 27% of type 1 diabetic patients develop DME within9 years of onset.The most common type of diabetes,type 2,is strongly associated with obesity and a sedentary lifestyle.An even higher incidence of macular edema has been reported in older patients with type 2diabetes.Within the last 5 years,the use of intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor(VEGF)agents have come into clinical practice for the management of DME and several recent randomized clinical trials have shown improved effectiveness of ranibizumab compared to focal/grid laser.In this theme issue,we discuss the classification of DR and the treatment options currently available for the treatment of DME including corticosteroids,anti-VEGF agents,combined therapy,enzymatic vitrectomy(vitreolysis),and new therapies. | J Fernando Arevalo | 2013 | World Journal of Diabetes2013，4，6： | 5 |
| 3 | Long-term hemodialysis improved and stabilized diabetic macular edema:two case reports显示文摘Dear Editor,Diabetic macular edema(DME)is one of main sightthreatening conditions in patients with diabetic retinopathy(DR)[1].Anti-vascular endothelial growth factor(VEGF)therapy,glucocorticoid therapy,laser photocoagulation。 | Wei Fan Rong-Di Yuan | 2021 | International Journal of Ophthalmology(English edition)2021，14，3： | 3 |
| 4 | 视网膜下注射平衡盐溶液治疗难治性糖尿病黄斑水肿一例显示文摘患者女,57岁。因右眼视力下降1年余,2016年10月收入我院。既往2型糖尿病20余年,目前口服药物血糖控制尚可。高血压病5年,口服药物血压控制尚可。 | 王佳琳 赵露 尤冉 王艳玲 | 2018 | 中华眼底病杂志2018，34，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员